drug protocol number

UX007-CL30

drug sponsor

Ultragenyx Pharmaceutical Inc

drug study

UX007/triheptanoin, Medium-chain Triglycerides (MCT),Dextrose. Monosaccharide. Blood Glucose-Elevating Agents.

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase